Allergan Plc
(NYSE : AGN)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
JAGXJaguar Health, Inc. 1.61%3.161.4%$411.73m
ZTSZoetis, Inc. -0.01%164.441.9%$261.34m
TEVATeva Pharmaceutical Industries Ltd. -1.34%11.812.0%$116.02m
RDYDr. Reddy's Laboratories Ltd. 0.02%68.722.0%$8.85m
COCPCocrystal Pharma, Inc. -4.98%2.100.0%$8.66m
TXMDTherapeuticsMD, Inc. -2.78%1.4020.1%$7.44m
ABEOAbeona Therapeutics, Inc. 0.00%1.983.8%$5.01m
TAROTaro Pharmaceutical Industries Ltd. 0.64%76.646.5%$2.00m
CPHIChina Pharma Holdings, Inc. -1.94%0.720.1%$1.80m
KINKindred Biosciences, Inc. -0.23%4.440.3%$1.15m
LFVNLifeVantage Corp. 0.00%9.253.3%$0.68m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.